AJCN EB 2010
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Olson, J. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Olson, J. A.
Agricola
Right arrow Articles by Olson, J. A.

American Journal of Clinical Nutrition, Vol 45, 687-692, Copyright © 1987 by The American Society for Clinical Nutrition, Inc


ORIGINAL RESEARCH COMMUNICATIONS

Recommended dietary intakes (RDI) of vitamin K in humans

JA Olson

Vitamin K is essential for the formation of at least three proteins involved in blood clotting as well as of other proteins found in plasma, bone, and kidney. Vitamin K deficiency, however, primarily affects the blood clotting process. Vitamin K is provided both from the diet and from endogenous bacterial synthesis, presumably in roughly equal measure. Because intakes of 0.4 micrograms X kg-1 X d-1 (0.89 nmol X kg-1 X d-1) and probably lower intakes maintain normal clotting activities in healthy neomycin-treated adults, rounded daily recommended dietary intakes (RDI) for essentially all reference 76-kg men and 62-kg women are 45 micrograms (100 nmol) and 35 micrograms (78 nmol) phylloquinone, respectively. Newborn infants are at high risk because breast milk contains inadequate concentrations of vitamin K and their intestines are not yet colonized with vitamin K-producing bacteria. Body reserves of vitamin K are small and turnover rapidly. Hence, supplementation of infants with vitamin K is highly advisable. Increments of vitamin K during pregnancy and lactation are also suggested.


This article has been cited by other articles:


Home page
The Annals of PharmacotherapyHome page
J. R Kuykendall, M. D Houle, and R. S Rhodes
Possible Warfarin Failure Due to Interaction with Smokeless Tobacco
Ann. Pharmacother., April 1, 2004; 38(4): 595 - 597.
[Abstract] [Full Text] [PDF]


Home page
JPEN J Parenter Enteral NutrHome page
M. J. Pettei, D. Israel, and J. Levine
Serum Vitamin K Concentration in Pediatric Patients Receiving Total Parenteral Nutrition
JPEN J Parenter Enteral Nutr, September 1, 1993; 17(5): 465 - 467.
[Abstract] [PDF]


Home page
JAMAHome page
J. B. Alperin
Coagulopathy Caused by Vitamin K Deficiency in Critically III, Hospitalized Patients
JAMA, October 9, 1987; 258(14): 1916 - 1919.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1987 by The American Society for Nutrition